Euro Diagnostica DIASTAT ANA (anti-nuclear antibody) ELISA DIASTAT ANA (anti-nuclear antibody) A positive ANA test result provides presumptive evidence for systemic rheumatic disease; further definition of specific antibody profiles is a valuable aid in the diagnostic process.
Published January 10, 2018 · Recall initiated: February 14, 2017
Summary
FDA records medical device Class II recall Z-0306-2018, published January 10, 2018 and initiated February 14, 2017. Recalling firm: Euro Diagnostica AB; Status: Terminated; Reported quantity: 534 kits; Lot: Lot: TS 2076. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Euro Diagnostica has identified a deviation in one of the components of the DIASTAT ANA (FANA200), lot TS 2076. The kit might not perform correctly and so potentially yield false positive samples.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Euro Diagnostica AB
- Distributor
- MN, NE, TX
- Lot
- Lot: TS 2076
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Sweden
Related recalls
- FDAImmunoscan CCPlus test kit is an enzyme-linked immunosorbent assay (ELISA) for qualitative andAugust 29, 2018
- FDARED SEXP DSTL FEM 19CM RT ASSY, model # CP111817January 10, 2018
- FDACADD-Legacy 1, Model 6400 Ambulatory Infusion Pump, REF 21-6400-51, PC 10008552-001, Smiths Medical ASD, Inc.January 10, 2018
- FDACER OPTION TYPE 1 TPR SLEVE -6, model # 650-1064January 10, 2018
- FDAAccess 2 Immunoassay System, Catalog Number 81600N. In vitro diagnostic device used for the quantitative,January 10, 2018
- FDADIASTAT(R) ANA (anti-Nuclear antibody) EURO DIAGNOSTICA, The DIASTAT(R) anti-nuclear antibody (ANA) test is aJuly 5, 2017
Questions about this recall
Was Euro Diagnostica DIASTAT ANA (anti-nuclear antibody) ELISA DIASTAT ANA (anti-nuclear antibody) A positive ANA test result provides presumptive evidence for systemic rheumatic disease; further definition of specific antibody profiles is a valuable aid in the diagnostic process. recalled?
Yes. FDA published recall Z-0306-2018 on January 10, 2018. Reported hazard: Euro Diagnostica has identified a deviation in one of the components of the DIASTAT ANA (FANA200), lot TS 2076. The kit might not perform correctly and so potentially yield false positive samples.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail